Tyche Industries

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE443B01012
  • NSEID:
  • BSEID: 532384
INR
107.00
1 (0.94%)
BSENSE

Mar 24

BSE+NSE Vol: 3.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.11 k (66.52%) Volume

Shareholding (Dec 2025)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

61.97%

Who are in the management team of Tyche Industries?

06-Jun-2025

As of March 2023, the management team of Tyche Industries includes G Ganesh Kumar (Chairman & Managing Director), Boosa Eswar (Independent Director), P Vijaya Lakshmi (Director), Panchakarla Sai Sudhakar (Independent Director), G Sandeep Kumar (Executive Director), Venkataraju Gupta Kollepalli (Non-Executive Director), Satya Ranjan Jena (Company Secretary & Compliance Officer), and Srinivas Gelli (Non-Executive Director).

As of March 2023, the management team of Tyche Industries includes the following individuals:<BR><BR>1. G Ganesh Kumar - Chairman & Managing Director<BR>2. Boosa Eswar - Independent Director<BR>3. P Vijaya Lakshmi - Director<BR>4. Panchakarla Sai Sudhakar - Independent Director<BR>5. G Sandeep Kumar - Executive Director<BR>6. Venkataraju Gupta Kollepalli - Non Executive Director<BR>7. Satya Ranjan Jena - Company Secretary & Compliance Officer<BR>8. Srinivas Gelli - Non Executive Director<BR><BR>These members play various roles in the governance and management of the company.

View full answer

Has Tyche Industries declared dividend?

06-Jun-2025

Yes, Tyche Industries has declared a dividend of 25% (amounting to $2.5 per share) with an ex-date of September 20, 2024. While the dividend yield is 1.79%, total returns have shown significant volatility, with negative returns in shorter periods and more favorable outcomes over the longer term.

Tyche Industries has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 25%<BR>- Amount per share: 2.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.79%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -34.69%, the dividend return was 0%, resulting in a total return of -34.69%.<BR><BR>For the 1-year period, the price return was -22.71%, the dividend return was 1.41%, leading to a total return of -21.3%.<BR><BR>Over 2 years, the price return was -23.92%, the dividend return was 2.40%, culminating in a total return of -21.52%.<BR><BR>In the 3-year period, the price return was 7.64%, the dividend return was 5.14%, resulting in a total return of 12.78%.<BR><BR>For the 4-year period, the price return was -36.26%, the dividend return was 3.09%, leading to a total return of -33.17%.<BR><BR>In the 5-year period, the price return was 26.65%, the dividend return was 6.46%, resulting in a total return of 33.11%.<BR><BR>Overall, Tyche Industries has declared a dividend, but the total returns over various periods show significant volatility, with negative returns in the shorter terms and a more favorable outcome over the longer term.

View full answer

Who are the peers of the Tyche Industries?

03-Jun-2025

Tyche Industries' peers include Sun Pharma, Divi's Lab, Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Lactose (India), Sotac Pharma, and Vaishali Pharma. Among these, Sun Pharma and Cipla show excellent management and growth, while Tyche Industries has a below-average growth rate and a 1-year return of -19.55%.

Peers: The peers of Tyche Industries are Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, BDH Industries, Lactose (India), Sotac Pharma., and Vaishali Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sun Pharma.Inds., Divi's Lab., Cipla, Torrent Pharma, Dr Reddy's Labs, and BDH Industries, while Below Average management risk is found at Lactose (India), Sotac Pharma., and Vaishali Pharma. Growth is Excellent for Sun Pharma.Inds., Cipla, and Dr Reddy's Labs, while Below Average growth is noted for Divi's Lab., Torrent Pharma, BDH Industries, Tyche Industries, Lactose (India), Vaishali Pharma, and the rest. Excellent capital structure is seen at Sun Pharma.Inds., Divi's Lab., Cipla, Dr Reddy's Labs, BDH Industries, and Tyche Industries, while Below Average capital structure is present at Lactose (India), Sotac Pharma., and Vaishali Pharma.<BR><BR>Return Snapshot: Divi's Lab. has the highest 1-year return at 51.96%, while Lactose (India) has the lowest at -35.55%. Tyche Industries' 1-year return is -19.55%, which is higher than Lactose (India) but lower than all other peers. Additionally, BDH Industries, Lactose (India), and Tyche Industries have negative six-month returns.

View full answer

What is the technical trend for Tyche Industries?

09-Jun-2025

As of June 2, 2025, Tyche Industries shows a mildly bearish trend overall, with mixed signals from key indicators like MACD and KST, while daily moving averages remain bearish.

As of 2 June 2025, the technical trend for Tyche Industries has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands are mildly bearish on both weekly and monthly time frames. Daily moving averages are bearish, and the KST is mildly bullish weekly but bearish monthly. Dow Theory shows no trend in both weekly and monthly perspectives. Overall, the current technical stance is mildly bearish, with key indicators being the bearish moving averages and the mixed signals from MACD and KST.

View full answer

What does Tyche Industries do?

17-Jul-2025

Tyche Industries Ltd is a micro-cap pharmaceutical company specializing in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates. As of March 2025, it reported net sales of 124 Cr and a net profit of 9 Cr, with a market cap of INR 149 Cr.

Overview: <BR>Tyche Industries Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology industry, primarily engaged in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates.<BR><BR>History: <BR>Incorporated on July 23, 1998, Tyche Industries Limited was formerly known as Siris Soft Limited. The latest quarterly results reported net sales and profit for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 124 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 9 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 149 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 12.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 1.76% <BR>Debt Equity: -0.62 <BR>Return on Equity: 9.07% <BR>Price to Book: 1.06 <BR><BR>Contact Details: <BR>Address: H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096 <BR>Tel: 91-40-23541688/23540933 <BR>Email: CS@tycheindustries.net <BR>Website: http://wwww.tycheindustries.net

View full answer

Who are the top shareholders of the Tyche Industries?

17-Jul-2025

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited with 19.31%, followed by Plutus Techlabs Private Limited at 6.4%. Individual investors collectively own 26.91%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited, which holds the highest stake at 19.31%. The company is primarily owned by its promoters, and there are no pledged promoter holdings. In terms of public shareholders, Plutus Techlabs Private Limited is the largest, with a holding of 6.4%. Additionally, individual investors collectively own 26.91% of the company. There are currently no mutual funds or foreign institutional investors holding shares in Tyche Industries.

View full answer

How big is Tyche Industries?

24-Jul-2025

As of 24th July, Tyche Industries Ltd has a market capitalization of 144.00 Cr, with recent net sales of 65.48 Cr and a net profit of 12.40 Cr. Shareholder's funds are 126.74 Cr, and total assets amount to 136.90 Cr.

As of 24th July, Tyche Industries Ltd has a market capitalization of 144.00 Cr, which categorizes it as a Micro Cap company.<BR><BR>In the latest four quarters, Tyche Industries reported Net Sales of 65.48 Cr and a Net Profit of 12.40 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 126.74 Cr and Total Assets of 136.90 Cr.

View full answer

How has been the historical performance of Tyche Industries?

15-Nov-2025

Tyche Industries has experienced declining net sales and profits from March 2023 to March 2025, with net sales dropping from INR 75.39 crore to INR 65.47 crore and profit after tax decreasing from INR 14.17 crore to INR 12.41 crore. However, total assets increased from INR 136.72 crore to INR 147.41 crore, primarily due to a rise in cash reserves.

Answer:<BR>The historical performance of Tyche Industries shows a fluctuating trend in key financial metrics over the years, with notable changes in net sales, profits, and assets.<BR><BR>Breakdown:<BR>Tyche Industries' net sales have seen a decline from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025, reflecting a downward trend over the last two years. The total operating income followed a similar pattern, decreasing from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025. Operating profit (PBDIT) also decreased from INR 20.98 crore in March 2023 to INR 18.71 crore in March 2025, indicating a reduction in profitability. The profit before tax showed a decline from INR 19.08 crore in March 2023 to INR 16.71 crore in March 2025, while profit after tax slightly decreased from INR 14.17 crore to INR 12.41 crore during the same period. On the balance sheet, total assets increased from INR 136.72 crore in March 2023 to INR 147.41 crore in March 2025, driven by growth in cash and bank balances, which rose from INR 69.28 crore to INR 84.26 crore. Total liabilities also increased from INR 136.72 crore to INR 147.41 crore, with no long-term or short-term borrowings reported throughout the years. Overall, Tyche Industries has experienced a mixed performance with declining sales and profits but an increase in total assets and cash reserves.

View full answer

Is Tyche Industries overvalued or undervalued?

20-Nov-2025

As of November 19, 2025, Tyche Industries is considered overvalued with a PE ratio of 13.01 and an EV to EBITDA of 15.16, lagging behind peers like Solar Industries and Godrej Industries, and has a year-to-date return of -36.01% compared to the Sensex's 9.02%.

As of 19 November 2025, Tyche Industries has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial ratios and peer comparisons. Key ratios include a PE ratio of 13.01, an EV to EBITDA of 15.16, and a Price to Book Value of 0.89, which indicate that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Tyche Industries' valuation appears less favorable; for instance, Solar Industries has a PE ratio of 94.38 and an EV to EBITDA of 58.08, while Godrej Industries shows a more attractive PE of 37.28 and an EV to EBITDA of 40.76. The significant divergence in valuation metrics suggests that Tyche Industries is not only overvalued relative to its own historical performance but also compared to its industry peers. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -36.01% compared to the Sensex's 9.02%, reinforcing the perception of overvaluation.

View full answer

When is the next results date for Tyche Industries Ltd?

06-Feb-2026

The next results date for Tyche Industries Ltd is 12 February 2026.

The next results date for Tyche Industries Ltd is scheduled for 12 February 2026.

View full answer

Are Tyche Industries Ltd latest results good or bad?

14-Feb-2026

Tyche Industries Ltd's latest results are concerning, with a 61.60% year-on-year decline in net profit and a 40.39% drop in net sales, leading to a 7.31% decrease in stock price. The company's operating margin has also significantly deteriorated, indicating serious profitability challenges.

Tyche Industries Ltd's latest results are concerning and can be classified as bad. The company reported a significant decline in both net profit and net sales for Q3 FY26. Net profit fell to ₹1.82 crore, which is a staggering 61.60% decrease year-on-year and 19.78% decrease quarter-on-quarter. Similarly, net sales dropped to ₹10.58 crore, reflecting a 40.39% decline year-on-year and a 25.28% decline from the previous quarter.<BR><BR>The operating margin has also deteriorated sharply, down to 10.30% from 27.27% a year ago, indicating serious challenges in maintaining profitability. This quarter's performance marks the lowest revenue figure in recent history and highlights a troubling trend of margin compression that has persisted throughout the fiscal year.<BR><BR>Overall, the results have led to a 7.31% drop in the stock price, signaling investor alarm over the company's deteriorating fundamentals and ongoing operational challenges. The outlook appears bleak, with structural issues in the core business and a heavy reliance on non-operating income further complicating the situation.

View full answer

Should I buy, sell or hold Tyche Industries Ltd?

15-Feb-2026

Why is Tyche Industries Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Tyche Industries Ltd is experiencing a decline in its stock price, currently at 107.30, reflecting a total decline of 7.42% year-to-date and 20.31% over the past year, significantly underperforming the broader market. Despite increased investor participation, the stock's performance metrics indicate a bearish trend.

As of 16-Mar, Tyche Industries Ltd is experiencing a decline in its stock price, currently at 107.30, which reflects a change of -3.3 or -2.98%. The stock has underperformed its sector by 2.17% today and has been on a consecutive downward trend for the last two days, with a total decline of -3.42% during this period. <BR><BR>In terms of intraday performance, the stock reached a high of Rs 112.9 but fell to a low of Rs 106, indicating significant volatility within the trading day. Additionally, Tyche Industries is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend in the stock's performance over various time frames.<BR><BR>Over the past week, the stock has decreased by 1.42%, while it has seen a more substantial decline of 7.78% over the past month. Year-to-date, the stock is down 7.42%, and over the past year, it has fallen by 20.31%. Comparatively, the Sensex has shown a decline of 11.40% year-to-date, indicating that while the broader market is also down, Tyche Industries has underperformed significantly.<BR><BR>Despite a notable increase in investor participation, with delivery volume rising by 488.35% against the 5-day average, the overall sentiment appears negative, contributing to the stock's decline. The liquidity of the stock remains adequate for trading, but the prevailing trends and performance metrics indicate a downward trajectory for Tyche Industries Ltd.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Poor long term growth as Net Sales has grown by an annual rate of -8.35% and Operating profit at -49.08% over the last 5 years

 
2

With a fall in PBT of -24.42%, the company declared Very Negative results in Dec 25

3

With ROE of 4.8, it has a Very Expensive valuation with a 0.8 Price to Book Value

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 110 Cr (Micro Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

2.83%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

4.77%

stock-summary
Price to Book

0.77

Revenue and Profits:
Net Sales:
11 Cr
(Quarterly Results - Dec 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.83%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.4%
0%
-7.4%
6 Months
-24.62%
0%
-24.62%
1 Year
-25.59%
2.19%
-23.4%
2 Years
-40.37%
3.04%
-37.33%
3 Years
-20.77%
4.93%
-15.84%
4 Years
-31.08%
6.06%
-25.02%
5 Years
-32.49%
5.78%
-26.71%

Latest dividend: 3 per share ex-dividend date: Sep-19-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Disclosures Under Reg. 10(6) Of SEBI (SAST) Regulations 2011

20-Mar-2026 | Source : BSE

Disclosure under Regulation 10(6) of SEBI(Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar

Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

20-Mar-2026 | Source : BSE

Enclosed the Disclosure under Regulation 10(6) of SEBI(SAST) Regulations 2011

Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

20-Mar-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for G Ganesh Kumar

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Tyche Industries Ltd has declared 30% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-8.35%
EBIT Growth (5y)
-49.08%
EBIT to Interest (avg)
9.50
Debt to EBITDA (avg)
0.16
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.63
Tax Ratio
26.26%
Dividend Payout Ratio
24.77%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
30.71%
ROE (avg)
10.52%

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
36
Price to Book Value
0.77
EV to EBIT
81.58
EV to EBITDA
29.88
EV to Capital Employed
0.72
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
2.83%
ROCE (Latest)
4.01%
ROE (Latest)
4.77%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Silver Oak Technologies Private Limited (19.31%)

Highest Public shareholder

Plutus Techlabs Private Limited (6.4%)

Individual Investors Holdings

26.51%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -25.28% vs 11.50% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 19.74% vs -37.45% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.58",
          "val2": "14.16",
          "chgp": "-25.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.09",
          "val2": "-0.13",
          "chgp": "938.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.82",
          "val2": "1.52",
          "chgp": "19.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.30%",
          "val2": "-0.92%",
          "chgp": "11.22%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.86",
          "val2": "36.06",
          "chgp": "-25.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.81",
          "val2": "7.33",
          "chgp": "-75.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "3.95",
          "val2": "6.72",
          "chgp": "-41.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.74%",
          "val2": "20.33%",
          "chgp": "-13.59%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.44",
          "val2": "53.81",
          "chgp": "-30.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.90",
          "val2": "12.17",
          "chgp": "-76.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.77",
          "val2": "11.46",
          "chgp": "-49.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.75%",
          "val2": "22.62%",
          "chgp": "-14.87%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "65.47",
          "val2": "69.51",
          "chgp": "-5.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.29",
          "val2": "12.65",
          "chgp": "-10.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "12.41",
          "val2": "12.24",
          "chgp": "1.39%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.24%",
          "val2": "18.20%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
10.58
14.16
-25.28%
Operating Profit (PBDIT) excl Other Income
1.09
-0.13
938.46%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
1.82
1.52
19.74%
Operating Profit Margin (Excl OI)
10.30%
-0.92%
11.22%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -25.28% vs 11.50% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is 19.74% vs -37.45% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
26.86
36.06
-25.51%
Operating Profit (PBDIT) excl Other Income
1.81
7.33
-75.31%
Interest
0.00
0.00
Exceptional Items
0.00
-0.70
100.00%
Standalone Net Profit
3.95
6.72
-41.22%
Operating Profit Margin (Excl OI)
6.74%
20.33%
-13.59%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -25.51% vs 8.98% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -41.22% vs 14.87% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
37.44
53.81
-30.42%
Operating Profit (PBDIT) excl Other Income
2.90
12.17
-76.17%
Interest
0.00
0.00
Exceptional Items
0.00
-0.70
100.00%
Standalone Net Profit
5.77
11.46
-49.65%
Operating Profit Margin (Excl OI)
7.75%
22.62%
-14.87%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -30.42% vs -2.71% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -49.65% vs 13.02% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
65.47
69.51
-5.81%
Operating Profit (PBDIT) excl Other Income
11.29
12.65
-10.75%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
12.41
12.24
1.39%
Operating Profit Margin (Excl OI)
17.24%
18.20%
-0.96%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is -5.81% vs -7.80% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 1.39% vs -13.62% in Mar 2024

stock-summaryCompany CV
About Tyche Industries Ltd stock-summary
stock-summary
Tyche Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Tyche Industries Limited was initially incorporated as Siris Soft Limited on July 23, 1998. The Company changed the name to 'Tyche Industries Limited' with due approval from the RoC in 2004. TIL is one of the largest manufacturers in India of Glucosamine Hydrochloride and corresponding sodium and potassium salts which are mainly exported to USA and Europe. Company's operations are predominantly related to the manufacture of bulk drugs intermediates.
Company Coordinates stock-summary
Company Details
H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096
stock-summary
Tel: 91-40-23541688/23540933
stock-summary
CS@tycheindustries.net
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad